CN1263476A - 一插入尿道的装置 - Google Patents
一插入尿道的装置 Download PDFInfo
- Publication number
- CN1263476A CN1263476A CN98805785A CN98805785A CN1263476A CN 1263476 A CN1263476 A CN 1263476A CN 98805785 A CN98805785 A CN 98805785A CN 98805785 A CN98805785 A CN 98805785A CN 1263476 A CN1263476 A CN 1263476A
- Authority
- CN
- China
- Prior art keywords
- urethra
- slender axles
- medicine
- passage
- back segment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000003708 urethra Anatomy 0.000 title claims abstract description 104
- 238000003780 insertion Methods 0.000 title claims abstract description 31
- 230000037431 insertion Effects 0.000 title claims abstract description 31
- 239000003814 drug Substances 0.000 claims abstract description 183
- 229940079593 drug Drugs 0.000 claims abstract description 29
- 239000012530 fluid Substances 0.000 claims abstract description 27
- 241001465754 Metazoa Species 0.000 claims abstract description 21
- 201000001881 impotence Diseases 0.000 claims description 29
- 208000010228 Erectile Dysfunction Diseases 0.000 claims description 25
- 230000000694 effects Effects 0.000 claims description 24
- BNRNXUUZRGQAQC-UHFFFAOYSA-N sildenafil Chemical compound CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 BNRNXUUZRGQAQC-UHFFFAOYSA-N 0.000 claims description 10
- 238000005461 lubrication Methods 0.000 claims description 7
- BLGXFZZNTVWLAY-CCZXDCJGSA-N Yohimbine Natural products C1=CC=C2C(CCN3C[C@@H]4CC[C@@H](O)[C@H]([C@H]4C[C@H]33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-CCZXDCJGSA-N 0.000 claims description 6
- BLGXFZZNTVWLAY-UHFFFAOYSA-N beta-Yohimbin Natural products C1=CC=C2C(CCN3CC4CCC(O)C(C4CC33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-UHFFFAOYSA-N 0.000 claims description 6
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 claims description 6
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 claims description 6
- 229960000317 yohimbine Drugs 0.000 claims description 6
- BLGXFZZNTVWLAY-SCYLSFHTSA-N yohimbine Chemical compound C1=CC=C2C(CCN3C[C@@H]4CC[C@H](O)[C@@H]([C@H]4C[C@H]33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-SCYLSFHTSA-N 0.000 claims description 6
- AADVZSXPNRLYLV-UHFFFAOYSA-N yohimbine carboxylic acid Natural products C1=CC=C2C(CCN3CC4CCC(C(C4CC33)C(O)=O)O)=C3NC2=C1 AADVZSXPNRLYLV-UHFFFAOYSA-N 0.000 claims description 6
- 239000000314 lubricant Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 210000004204 blood vessel Anatomy 0.000 claims description 4
- 229910002651 NO3 Inorganic materials 0.000 claims description 3
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims description 3
- 239000008896 Opium Substances 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 150000001336 alkenes Chemical class 0.000 claims description 3
- 239000002269 analeptic agent Substances 0.000 claims description 3
- 230000003555 analeptic effect Effects 0.000 claims description 3
- 239000005557 antagonist Substances 0.000 claims description 3
- HSWPZIDYAHLZDD-UHFFFAOYSA-N atipamezole Chemical compound C1C2=CC=CC=C2CC1(CC)C1=CN=CN1 HSWPZIDYAHLZDD-UHFFFAOYSA-N 0.000 claims description 3
- 229960003002 atipamezole Drugs 0.000 claims description 3
- 239000000480 calcium channel blocker Substances 0.000 claims description 3
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 claims description 3
- 229960001076 chlorpromazine Drugs 0.000 claims description 3
- 238000007599 discharging Methods 0.000 claims description 3
- 229960003638 dopamine Drugs 0.000 claims description 3
- 238000012377 drug delivery Methods 0.000 claims description 3
- 229960003133 ergot alkaloid Drugs 0.000 claims description 3
- 229960003878 haloperidol Drugs 0.000 claims description 3
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 claims description 3
- 229960001027 opium Drugs 0.000 claims description 3
- IENZQIKPVFGBNW-UHFFFAOYSA-N prazosin Chemical compound N=1C(N)=C2C=C(OC)C(OC)=CC2=NC=1N(CC1)CCN1C(=O)C1=CC=CO1 IENZQIKPVFGBNW-UHFFFAOYSA-N 0.000 claims description 3
- 229960001289 prazosin Drugs 0.000 claims description 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 3
- 150000003180 prostaglandins Chemical class 0.000 claims description 3
- 210000002307 prostate Anatomy 0.000 claims description 3
- 229960003310 sildenafil Drugs 0.000 claims description 3
- JSPLKZUTYZBBKA-UHFFFAOYSA-N trioxidane Chemical compound OOO JSPLKZUTYZBBKA-UHFFFAOYSA-N 0.000 claims description 3
- 229940044551 receptor antagonist Drugs 0.000 claims description 2
- 239000002464 receptor antagonist Substances 0.000 claims description 2
- 229940124597 therapeutic agent Drugs 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- 230000000246 remedial effect Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 238000009434 installation Methods 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 201000011264 priapism Diseases 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 229940094720 viagra Drugs 0.000 description 2
- 239000004605 External Lubricant Substances 0.000 description 1
- 239000000670 adrenergic alpha-2 receptor antagonist Substances 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- 239000012744 reinforcing agent Substances 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/06—Body-piercing guide needles or the like
- A61M25/0662—Guide tubes
- A61M2025/0681—Systems with catheter and outer tubing, e.g. sheath, sleeve or guide tube
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9702147A SE9702147D0 (sv) | 1997-06-05 | 1997-06-05 | A transurethral device |
SE97021471 | 1997-06-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1263476A true CN1263476A (zh) | 2000-08-16 |
Family
ID=20407263
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN98805785A Pending CN1263476A (zh) | 1997-06-05 | 1998-05-29 | 一插入尿道的装置 |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0986417A1 (xx) |
JP (1) | JP2002502290A (xx) |
KR (1) | KR20010049181A (xx) |
CN (1) | CN1263476A (xx) |
AR (1) | AR012857A1 (xx) |
AU (1) | AU8045398A (xx) |
BR (1) | BR9809552A (xx) |
CA (1) | CA2291612A1 (xx) |
EE (1) | EE9900563A (xx) |
HU (1) | HUP0001919A3 (xx) |
IL (1) | IL133041A0 (xx) |
IS (1) | IS5271A (xx) |
NO (1) | NO995962D0 (xx) |
PL (1) | PL337450A1 (xx) |
SE (1) | SE9702147D0 (xx) |
SK (1) | SK165999A3 (xx) |
TR (1) | TR199902959T2 (xx) |
WO (1) | WO1998055176A1 (xx) |
ZA (1) | ZA984537B (xx) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1791501A (en) * | 1999-11-22 | 2001-06-04 | Epix Medical, Inc. | Imaging sexual response |
US20060189695A1 (en) * | 2003-06-25 | 2006-08-24 | Cardiovascular Institute, Ltd | External preparation for improving coital function |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR562564A (fr) * | 1923-02-22 | 1923-11-14 | Pose-crayon pour l'usage intra-utérin et intra-urétral | |
CH302318A (de) * | 1952-05-09 | 1954-10-15 | Wolfgang Dr Med Bachmann | Medizinisches Gerät. |
US3256884A (en) * | 1963-04-15 | 1966-06-21 | Hill | Injection device for artificial insemination having a disposable dispensing capsule with detachable actuator |
JPH034282Y2 (xx) * | 1986-09-16 | 1991-02-04 | ||
US5482039A (en) * | 1994-03-25 | 1996-01-09 | Vivus, Inc. | Process for diagnosing erectile dysfunction, and related methods of treatment |
-
1997
- 1997-06-05 SE SE9702147A patent/SE9702147D0/xx unknown
-
1998
- 1998-05-26 AR ARP980102435A patent/AR012857A1/es unknown
- 1998-05-27 ZA ZA984537A patent/ZA984537B/xx unknown
- 1998-05-29 AU AU80453/98A patent/AU8045398A/en not_active Abandoned
- 1998-05-29 IL IL13304198A patent/IL133041A0/xx unknown
- 1998-05-29 KR KR1019997011399A patent/KR20010049181A/ko not_active Application Discontinuation
- 1998-05-29 PL PL98337450A patent/PL337450A1/xx unknown
- 1998-05-29 CA CA002291612A patent/CA2291612A1/en not_active Abandoned
- 1998-05-29 EP EP98928726A patent/EP0986417A1/en not_active Withdrawn
- 1998-05-29 TR TR1999/02959T patent/TR199902959T2/xx unknown
- 1998-05-29 CN CN98805785A patent/CN1263476A/zh active Pending
- 1998-05-29 JP JP50224699A patent/JP2002502290A/ja active Pending
- 1998-05-29 HU HU0001919A patent/HUP0001919A3/hu unknown
- 1998-05-29 SK SK1659-99A patent/SK165999A3/sk unknown
- 1998-05-29 WO PCT/SE1998/001029 patent/WO1998055176A1/en not_active Application Discontinuation
- 1998-05-29 BR BR9809552-8A patent/BR9809552A/pt not_active Application Discontinuation
- 1998-05-29 EE EEP199900563A patent/EE9900563A/xx unknown
-
1999
- 1999-11-24 IS IS5271A patent/IS5271A/is unknown
- 1999-12-03 NO NO995962A patent/NO995962D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO995962L (no) | 1999-12-03 |
BR9809552A (pt) | 2000-06-20 |
CA2291612A1 (en) | 1998-12-10 |
IS5271A (is) | 1999-11-24 |
EP0986417A1 (en) | 2000-03-22 |
SK165999A3 (en) | 2000-07-11 |
EE9900563A (et) | 2000-06-15 |
KR20010049181A (ko) | 2001-06-15 |
SE9702147D0 (sv) | 1997-06-05 |
AR012857A1 (es) | 2000-11-22 |
JP2002502290A (ja) | 2002-01-22 |
PL337450A1 (en) | 2000-08-14 |
AU8045398A (en) | 1998-12-21 |
WO1998055176A1 (en) | 1998-12-10 |
HUP0001919A3 (en) | 2000-12-28 |
NO995962D0 (no) | 1999-12-03 |
ZA984537B (en) | 1998-12-07 |
HUP0001919A2 (hu) | 2000-10-28 |
IL133041A0 (en) | 2001-03-19 |
TR199902959T2 (xx) | 2000-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6478790B2 (en) | Implant device and dosage form employable therein | |
US5562613A (en) | Subcutaneous drug delivery device | |
KR100359587B1 (ko) | 비침 비경구 장치 및 비경구 투여용 약제 | |
TWI573603B (zh) | 輸送流體及物質至一對象之裝置 | |
US8845596B2 (en) | Focused dosimetry device and methods associated therewith | |
WO2020118165A1 (en) | Subcutaneous delivery of high concentration formulations | |
AR031880A1 (es) | Dispositivo de liberacion sustentada implantable para administrar localmente un medicamento | |
CA2407912A1 (en) | Method and apparatus for diagnostic and therapeutic agent delivery | |
KR930700048A (ko) | 발기 기능장애 치료 방법 | |
US11541043B2 (en) | Low concentration delivery of an ergoline derivative for treatment of a headache | |
WO2000072910A1 (en) | Method and apparatus for placement and activation of a medical device within a body cavity | |
ES2808982T3 (es) | Un conjunto de jeringa | |
CN1263476A (zh) | 一插入尿道的装置 | |
JP3035448U (ja) | 歯周ポケット用薬剤注入器 | |
US9566141B2 (en) | Medicinal implant device and cartridge | |
FR2564734A1 (fr) | Moyens et procede pour administrer des medicaments | |
US9987267B2 (en) | Transdermal formulations of pergolide and uses thereof | |
WO1995007672A1 (en) | Rectally-administered, epileptic-seizure-inhibiting composition | |
US20230149639A1 (en) | A syringe, a method for manufacturing such syringes and an assembly | |
CZ432199A3 (cs) | Transuretrální zařízení | |
WO2023166440A1 (en) | An auto disable single use syringe | |
CN1163578A (zh) | 无针非胃肠给药装置 | |
CN111905193A (zh) | 一种注射装置 | |
JPS60256467A (ja) | 医療用投薬の方法と手段 | |
RU2000100329A (ru) | Трансуретральное устройство |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C01 | Deemed withdrawal of patent application (patent law 1993) | ||
WD01 | Invention patent application deemed withdrawn after publication |